返回 Agenda
Session 4: Track A: Regulatory Renewal: More on the Regulatory Changes Implemented and Being Proposed
Session Chair(s)
Lisa Chartrand
Director, Regulatory Strategy and Policy , Hoffmann-La Roche Limited, Canada
Following on from Session 3A, given the unprecedented number of regulatory changes being proposed in the last year (and in the next few years to come) which affect various stages of a product’s lifecycle in Canada, this session will summarize, consolidate, clarify, and help to ensure as an industry and consumers that we are all prepared.
Learning Objective : At the conclusion of this session, participants should be able to:- Recognize the overarching mandate to the various regulatory changes being implemented and proposed
- Describe the role of stakeholder input as part of the open consultation process
- Prepare your organization for the regulatory changes
Speaker(s)
Bruno Rodrigue
Director, Office of Legislation and Regulatory Modernization, Health Canada, Canada
Speaker
Kristen Beausoleil
Manager, Economic Analysis, Office of Legislative and Regulatory Modernization, Health Canada, Canada
Speaker
Julie Chateauvert, MS
Senior Scientific Project Coordination Biologist, Health Canada, Canada
Proposal for the Environmental Risk Assessment of Medicinal Ingredients in Human and Veterinary Drugs
Jared Rhines
General Manager, AKCEA Therapeutics Canada Inc, Canada
Industry Impact Regulatory Changes